Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, Regenxbio Inc’s stock clocked out at $6.95, down -7.46% from its previous closing price of $7.51. In other words, the price has decreased by -$7.46 from its previous closing price. On the day, 1.19 million shares were traded. RGNX stock price reached its highest trading level at $7.7 during the session, while it also had its lowest trading level at $6.56.
Ratios:
To gain a deeper understanding of RGNX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.05 and its Current Ratio is at 3.05. In the meantime, Its Debt-to-Equity ratio is 0.48 whereas as Long-Term Debt/Eq ratio is at 0.37.
On June 07, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $38.Goldman initiated its Buy rating on June 07, 2024, with a $38 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 30 ’24 when VITTAL VASISTA bought 20,041 shares for $7.41 per share.
KARABELAS ARGERIS N sold 10,000 shares of RGNX for $101,052 on Oct 01 ’24. The Director now owns 11,286 shares after completing the transaction at $10.11 per share. On Sep 03 ’24, another insider, KARABELAS ARGERIS N, who serves as the Director of the company, sold 10,000 shares for $11.56 each. As a result, the insider received 115,588 and left with 11,286 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RGNX now has a Market Capitalization of 372083520 and an Enterprise Value of 234689248. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.08 while its Price-to-Book (P/B) ratio in mrq is 1.14. Its current Enterprise Value per Revenue stands at 2.783 whereas that against EBITDA is -1.05.
Stock Price History:
The Beta on a monthly basis for RGNX is 1.29, which has changed by -0.508186 over the last 52 weeks, in comparison to a change of 0.22263205 over the same period for the S&P500. Over the past 52 weeks, RGNX has reached a high of $28.80, while it has fallen to a 52-week low of $7.14. The 50-Day Moving Average of the stock is -22.62%, while the 200-Day Moving Average is calculated to be -43.49%.
Shares Statistics:
It appears that RGNX traded 1.15M shares on average per day over the past three months and 1285020 shares per day over the past ten days. A total of 49.53M shares are outstanding, with a floating share count of 44.68M. Insiders hold about 9.82% of the company’s shares, while institutions hold 90.23% stake in the company. Shares short for RGNX as of 1734048000 were 6229382 with a Short Ratio of 5.24, compared to 1731628800 on 4615030. Therefore, it implies a Short% of Shares Outstanding of 6229382 and a Short% of Float of 16.440001000000002.
